Spectral MD Full Year Trading Updates and Notice of Results
Feb 7, 2022
DALLAS - February 7, 2022 - (Newswire.com)
Spectral MD, a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, provides a trading update for the year ended Dec. 31, 2021.
The Company can confirm that both its unaudited loss for the year and negative EBITDA are expected to be materially ahead of current market expectations with the Dec. 31, 2021, unaudited cash position also marginally ahead of expectations. This has been primarily driven by lower costs per subject associated with the Diabetic Foot Ulcer ("DFU") clinical training study. Additionally, unaudited grant revenue, deriving from the Company's BARDA funding contract for the Burn indication, is expected to be broadly in line with market expectations.
Notice of Results
The Company intends to publish its audited preliminary results for the year ended Dec. 31, 2021, by the end of March.
Wensheng Fan, CEO of Spectral MD, said: "Spectral MD continues to make good progress on its clinical and regulatory pathway, and the Company is on track to deliver on its expected milestones notwithstanding the continued challenges of the COVID pandemic. Cash and loss for the year are both expected to have exceeded expectations, with BARDA contract revenue broadly in line with expectations. I look forward to providing further updates at the time of the preliminary results."
Funding and technical support for development of DeepView® Wound Imaging System is provided by the Biomedical Advanced Research and Development Authority (BARDA), under the Assistant Secretary for Preparedness and Response (ASPR), within the U.S. Department of Health and Human Services (HHS), under ongoing USG Contract No. 75A50119C00033. For more information about BARDA, refer to https://www.medicalcountermeasures.gov/.
About Spectral MD:
We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView® Wound Imaging System.
Spectral MD devices are in various stages of research and development including pre-clinical testing and clinical investigations. At this time, no Spectral MD devices have received marketing authorization and therefore, are not available for sale in the USA.
www.spectralmd.com
Press Release Service by Newswire.com
Original Source: Spectral MD Full Year Trading Updates and Notice of Results
More News
China Steps In to Rescue Stocks, But the Market Continues to Fall
The Communist Party uses a “national team” of state-owned investment funds to stem the market rout. But this time, investors are not sure it will work.
Mbappé sorry for 'ill-judged' Mao remark after backlash in China
The France star had referred to the former Chinese leader as a "dictator" during an interview about memes.
I'm a single mum on £41,000 and limit my weekly shop to £40 - it's hard
People earning from £380 a month to £150,000 a year tell the BBC what they want to see in this year's Budget.
California’s Potential Quartz Ban Pushes Contractors and Retailers to Alternatives
Manufacturers and their customers are using materials made without the clouds of dust that have sickened workers in quartz-cutting shops.
My Co-Worker Is Losing It Over My Religion
Plus: Reader responses to a woman returning to the office after two decades of self-employment.
My Co-Worker Is Losing It Over My Religion
Plus: Reader responses to a woman returning to the office after two decades of self-employment.
First-time buyer wary of Budget housing loan scheme
Luke Anstee has been saving for three years but says rising living costs make home ownership harder.
Holiday Travel Costs Are Soaring. Here’s How to Save.
As airfares and gas prices surge, here’s how you can extend your travel budget.
U.S. Pensions Are Riding the A.I. Wave. For Better or Worse.
As exuberance around the technology stokes fears of a bubble, the nation’s public pensions are starting to grapple with their role — and their risks.
In Anthropic I.P.O., Goldman and Morgan Stanley Slug It Out for Top Bank
Anthropic named the Wall Street firms lead underwriters on its upcoming public offering, a role that will generate generous fees and enormous prestige.
Apple to replace iPhone Duos affected by screen problem
Photos shared online showed faults appearing on the screens of Apple's first foldable device.
In Anthropic I.P.O., Goldman and Morgan Stanley Slug It Out for Top Bank
Anthropic named the Wall Street firms lead underwriters on its upcoming public offering, a role that will generate generous fees and enormous prestige.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.